| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |